Saturday, December 15, 2018

Leprosy target: Global elimination by 2020 a dream only ?

What is leprosy

Leprosy (also known as Hansen’s disease) is a chronic infectious disease caused by bacteria, mainly spread through droplets from the nose and mouth of people suffering from untreated leprosy.
The disease, which can have a long incubation period, causes disfiguring lesions on the skin and nerve damage.
The first stage of leprosy leads to loss of sensation and muscle weakness in facial muscles, hands, and feet (known as Grade 1 disability).
If the disease is not detected and treated, it progresses to a second stage that causes observable and permanent impairments, such as loss and shortening of fingers and toes, and vision loss (known as Grade 2 disability).
Leprosy is most common in areas of poverty, where overcrowding and poor nutrition make people more vulnerable to infection, and where it continues to be a major source of disability and social exclusion for persons affected and their families. The consequences of leprosy can often persist beyond completion of treatment.

People affected by leprosy

3 countriesACCOUNT FOR MORE THAN 80% OF THE GLOBAL BURDEN (BRAZIL, INDIA AND INDONESIA) 174,608 casesRECEIVED TREATMENT AT THE START OF 2016

WHO NTD roadmap targets for leprosy

The World Health Organization’s roadmap on NTDs set out a comprehensive plan for the control, elimination and eradication of various neglected tropical diseases by 2020, including leprosy.
Leprosy target: Global elimination by 2020

Progress, year after year

Here are some of the numbers that give us much 
reason to celebrate:
Human African trypanosomiasis2,184 cases reported in 2016. 
Down from 10,000 cases in 2009
Trachoma5 countries have eliminated trachoma as a public health problem since 2012

Lymphatic filariasis544 million people no longer require treatment for LF. A drop of 39%Guinea worm diseaseOnly 26 cases reported so far in 2017. A drop from 3 million, 30 years agoOnchocerciasis4 countries in the Americas have eliminated onchocerciasis since 2012

No comments: